Preventing Relapse: The Role of LAIs in Schizophrenia
In this episode, we explore when and why long-acting injectable antipsychotics (LAIs) should be considered for patients with schizophrenia, covering approved indications, ideal candidate profiles, and the critical role of shared decision-making in treatment planning. Faculty: Brian Miller, M.D., Ph.D., M.P.H. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia Understanding When to Prescribe LAIs
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Psychopharmacology and Psychiatry Updates
Mastering Long-Acting Injectables: Aripiprazole & Olanzapine
Predicting Lithium Response in Bipolar Disorder
Could Lithium Play a Role in Preventing Alzheimer's Disease?
Managing ADHD in Pregnancy: Weighing Risk versus Risk
Get summaries like this every morning.
Free AI-powered recaps of Psychopharmacology and Psychiatry Updates and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.